MICHAEL HENDERSON - 31 Jan 2025 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Chief Executive Officer, Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Michael Henderson
Issuer symbol
APGE
Transactions as of
31 Jan 2025
Transactions value $
$194,310
Form type
4
Filing time
31 Jan 2025, 20:00:12 UTC
Previous filing
14 Jan 2025
Next filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APGE Common Stock Options Exercise $194,310 +8,500 +0.65% $22.86 1,317,987 31 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Options Exercise $0 -8,500 -2.13% $0 390,012 31 Jan 2025 Common Stock 8,500 $22.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 398,512 shares of the Issuer's common stock, one quarter of which vested on December 18, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.